KC
TLSIW icon

Kepos Capital’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Kepos Capital’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-145,000
Closed -$7K – 317
2023
Q2 		$7K Buy
+145,000
New +$9.85K ﹤0.01% 319
2022
Q4 		$11K Hold
145,000
– – ﹤0.01% 355
2022
Q3 		$9K Hold
145,000
– – ﹤0.01% 426
2022
Q2 		$12K Hold
145,000
– – ﹤0.01% 472
2022
Q1 		$37K Hold
145,000
– – ﹤0.01% 552
2021
Q4 		$76K Buy
+145,000
New +$133K 0.01% 564

Other funds holding TLSIW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Kepos Capital's TLSIW Position: Q3 2023 in Review

Kepos Capital sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2023, closing a stake of 145,000 shares — an estimated $7K sold.

Kepos Capital first reported a position in TLSIW in Q4 2021 and held it in 6 quarters. The position peaked at $76K in Q4 2021. 19 funds tracked by Wall St. Rank hold TLSIW as of Q3 2023.

  • Kepos Capital reported no remaining TriSalus Life Sciences Warrant position as of Q3 2023 after selling out during the quarter.
  • Kepos Capital sold 145,000 TriSalus Life Sciences Warrant shares in Q3 2023, an estimated $7K.
  • Kepos Capital first reported a position in TriSalus Life Sciences Warrant in Q4 2021 and held it in 6 quarters.
  • Kepos Capital's TriSalus Life Sciences Warrant position peaked at $76K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2023.

Based on Kepos Capital's 13F filing for Q3 2023, filed 14 Nov 2023.